跳至主要内容
临床试验/NCT01778452
NCT01778452已完成不适用

Profile Study of Genomics Endometrial Expression After Gonadotropin-releasing Hormone Agonist Administration and GnRH in Endometrial Priming.

Instituto Valenciano de Infertilidad, IVI VALENCIA2 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2009年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
6
试验地点
2
主要终点
genetic endometrial human profile expression

研究概览

简要总结

The aim of this study is to analyse genomics profile expression in endometrium under different endometrial priming for recipients.

详细描述

We analyze the genomic profile of egg donors in different endometrial priming protocols, compared with natural cycle, including the conventional single long acting GnRH agonist injection in the mid luteal phase of the previous cycle of the endometrial priming and the single daily antagonist injection (Cetrorelix 0.25 mg) administered in the early follicular phase followed by endometrial priming. Endometrial biopsy will be taken in luteinizing hormone

  • 7 or with P4 +5 in cases with endometrial priming with oestrogens therapy.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • 6 egg healthy volunteer egg donors.
  • Volunteers.
  • 18-35 years old
  • BMI <28.

排除标准

  • - BMI > 28

结局指标

主要结局

genetic endometrial human profile expression

时间窗: Oocyte donors will be followed up for four to six months

implantation related genes profile expression

次要结局

未报告次要终点

研究者

发起方
Instituto Valenciano de Infertilidad, IVI VALENCIA
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Endometrial Genomic Profile in Endometrial Priming | 临床试验